Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 533-540

  Gross, Garrett J ^a   Mei, David A ^a   Sleph, Paul G ^b   Grover, Gary J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; BIMAKALIM; GLIBENCLAMIDE; LACTATE DEHYDROGENASE; POTASSIUM CHANNEL; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE RECEPTOR; BENZOPYRAN DERIVATIVE; CARDIOTONIC AGENT; DIHYDROPYRIDINE DERIVATIVE; PHENYLISOPROPYLADENOSINE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG ANTAGONISM; ENZYME RELEASE; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; CHANNEL GATING; DRUG EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; IN VITRO STUDY; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOPYRANS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DIHYDROPYRIDINES; DOGS; HEART RATE; ION CHANNEL GATING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PHENYLISOPROPYLADENOSINE; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; REGRESSION ANALYSIS; VENTRICULAR FUNCTION, LEFT; XANTHINES;

EID: 0030614333     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. AL-AQATI, Q.: Regulation of ion channels by ABC transporters that secrete ATP. Science (Wash. DC) 269: 805-806, 1995.
2. ARMSTRONG, S. C. AND GANOTE, C. E.: In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: Effects of selective adenosine receptor blockade and calphostin C. Cardiovasc. Res. 29: 647-652, 1995.
3. ARMSTRONG, S. C., LIU, G. S., DOWNEY, J. M. AND GANOTE, C. E.: Potassium channels and preconditioning of isolated rabbit cardiomyocytes: Effects of glyburide and pinacidil. J. Mol. Cell. Cardiol. 27: 1765-1774, 1995.
4. ATWAL, K. S., GROVER, G. J., ARMED, S., FERRARA, F. N., HARPER, T. W., KIM, K. S., SLEPH, P. G., DZWONCZYK, S., RUSSELL, A. D., MORELAND, S., MCCULLOUGH, J. R. AND NORMANDIN, D. E.: Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J. Med. Chem. 36: 3971-3974, 1993.
5. ATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. 264: H1327-H1336, 1993.
6. + channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J. Pharmacol. Exp. Ther. 259: 961-967, 1991.
7. DOWNEY, J. M., LIU, G. S. AND THORNTON, J. D.: Adenosine and the anti-infarct effects of preconditioning. Cardiovasc. Res. 27: 3-8, 1993.
8. EDWARDS, G. AND WESTON, A. H.: The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol. 33: 597-637, 1993.
9. FRALIX, T. A., STEENBERGEN, C., LONDON, R. E. AND MURPHY, E.: Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc. Res. 27: 630-637, 1993.
10. ATP channel as a receptor for potassium channel openers. J. Biol. Chem. 271: 8796-8799, 1996.
11. GROSS, G. J. AND AUCHAMPACH, J. A.: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
12. GROSS, G. J. AND SCHULTZ, J. E. J.: Glibenclamide abolishes ischemic preconditioning in a time-dependent manner in the rat heart. FASEB J. 10: A140, 1996.
13. GROVER, G. J.: Protective effects of ATP-sensitive potassium channel openers in experimental rnyocardial ischemia. J. Cardiovasc. Pharmacol. 24: suppl 4, S18-S27, 1994.
14. 1 receptors in ischemic rat hearts. Cardiovasc. Res. 31: 511-517, 1996.
15. GROVER, G. J., D'ALONZO, A. J., HESS, T., SLEPH, P. G. AND DARBENZIO, R. B.: Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc. Res. 30: 731-738, 1995.
16. GROVER, G. J., NEWBURGER, J., SLEPH, P. G., DZWONCZYK, S., TAYLOR, S. C., AHMED, S. Z. AND ATWAL, K. S.: Cardioprotective effects of the potassium channel opener cromakalim: Stereoselectivity and effects on myocardial adenine nucleotides. J. Pharmacol. Exp. Then 257: 156-162, 1991.
17. 1 receptor activation. J. Pharmacol. Exp. Ther. 268: 90-96, 1994.
18. ATP openers in ischemic rat hearts treated with a potassium cardioplegic solution. J. Cardiovasc. Pharmacol. 265: 695-706, 1995.
19. 1-receptors. Circulation 86: 1310-1316, 1992.
20. 1 receptors by G proteins in rat ventricular myocytes. Am. J. Physiol. 258: H820-H826, 1990.
21. + channels mimics the infarct size limiting effect of ischemic preconditioning: Role of activatior of ectosolic 5′-nucleotidase. Am. J. Physiol. 270: H1744-H1756, 1996.
22. + channel-dependent as well as independent components of pinacidil-induced vasodilation. J. Pharmacol. Exp. Ther. 256: 492-499, 1991.
23. MIZUMURA, T., NITHIPATIKOM, K. AND GROSS, G. J.: Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 92: 1236-1245, 1995.
24. OHTA, H., JINNO, Y., OGAWA, N., FUKUSHIMA, H. AND NISHIKORE, J.: Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Eur. J. Pharmacol. 204: 171-177, 1991.
25. SARGENT, C. A., SMITH, M. A., DZWONCZYK, S., SLEPH, P. G. AND GROVER, G. J.: Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents. J. Pharmacol. Exp. Ther. 259: 97-103, 1991.
26. + channel blocker. Circulation 90: 700-705, 1994.
27. TOOMBS, C. F., MCGEE, D. S., JOHNSTON, W. E. AND VINTEN-JOHANSEN, J.: Protection from ischaemic-reperfusion injury with adenosine treatment is reversed by inhibition of ATP-sensitive potassium channels. Cardiovasc. Res. 27: 623-629, 1993a.
28. TOOMBS, C. F., MOORE, T. L. AND SHEBUSKI, R. J.: Limitation of infarct size in the rabbit by ischemic preconditioning is reversible with glibenclamide. Cardiovasc. Res. 27: 617-622, 1993b.
29. ATP channel. Am. J. Physiol. 266: H829-H839, 1994.
30. ATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc. Res. 28: 1337-1342, 1994.
31. YAO, Z. AND GROSS, G. J.: Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am. J. Physiol. 267: H1888-H1894, 1994a.
32. ATP opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 89: 1769-1775, 1994b.